Healthcare Capital Corp. Announces Pricing of Upsized $240 Million Initial Public Offering
14 Janeiro 2021 - 10:08PM
Healthcare Capital Corp. (the “Company”), a newly incorporated
blank check company, today announced the pricing of its upsized
initial public offering of 24,000,000 units at a price of $10.00
per unit. The units are expected to be listed on the Nasdaq Capital
Market (“Nasdaq”) and trade under the ticker symbol “HCCCU”
beginning January 15, 2021. Each unit consists of one share of
Class A common stock and one-half of one redeemable warrant. Each
whole warrant entitles the holder thereof to purchase one share of
Class A common stock at a price of $11.50 per share. Only whole
warrants are exercisable. Once the securities comprising the units
begin trading separately, the Company expects that the shares of
Class A common stock and redeemable warrants will be listed on the
Nasdaq under the symbols “HCCC” and “HCCCW,” respectively.
The Company was formed for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase,
reorganization or similar business combination with one or more
businesses. While the Company may pursue an initial business
combination target in any industry, it currently intends to
concentrate its search for a target business operating in the
healthcare industry, with a focus on digital and telehealth, life
sciences, innovative medical devices and healthcare technology
The Company is led by Dr. David Milch, Chairman of the Board;
William Johns, Chief Executive Officer and Director; and Philip A.
Baseil, Chief Financial Officer.
Cantor Fitzgerald & Co. is serving as sole bookrunner. The
Company has granted the underwriters a 45-day option to purchase up
to an additional 3,600,000 units at the initial public offering
price to cover over-allotments, if any.
The offering is being made only by means of a prospectus, copies
of which may be obtained by contacting Cantor Fitzgerald & Co.,
Attention Capital Markets, 499 Park Avenue, New York, NY 10022, or
by e-mail at prospectus@cantor.com.
A registration statement relating to these securities was
declared effective by the Securities and Exchange Commission (the
“SEC”) on January 14, 2021. This press release shall not constitute
an offer to sell or a solicitation of an offer to buy, nor shall
there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any
such state or jurisdiction.
Forward-Looking Statements
This press release contains statements that constitute
"forward-looking statements," including with respect to the
proposed initial public offering and the anticipated use of the net
proceeds. No assurance can be given that the offering discussed
above will be completed on the terms described, or at all, or that
the net proceeds of the offering will be used as indicated.
Forward-looking statements are subject to numerous conditions, many
of which are beyond the control of the Company, including those set
forth in the Risk Factors section of the Company's registration
statement and preliminary prospectus for the Company's offering
filed with the SEC. Copies of these documents are available on the
SEC's website, www.sec.gov. The Company undertakes no
obligation to update these statements for revisions or changes
after the date of this release, except as required by law.
Contacts
William Johns
bill@wjohns.com
Healthcare Capital (NASDAQ:HCCCU)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Healthcare Capital (NASDAQ:HCCCU)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024